| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.002 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.011 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.0075 | 1 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.0085 | 1 |